DAX25.001 +1,1%Est506.263 +0,8%MSCI World4.343 -0,1%Top 10 Crypto7,6800 -0,7%Nas25.388 -0,4%Bitcoin52.116 -3,0%Euro1,1380 +0,2%Öl74,61 +2,0%Gold4.039 +1,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 SpaceX A42D4F Micron Technology 869020 Bayer BAY001 Infineon 623100 NVIDIA 918422 Lufthansa 823212 SAP 716460 Siemens Energy ENER6Y TKMS thyssenkrupp Marine Systems TKMS00 Volkswagen (VW) vz. 766403 Microsoft 870747 Deutsche Telekom 555750 RENK RENK73 Take Two 914508
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Erholung: DAX schließt fester -- Micron: Mega-Gewinnwachstum dank KI-Boom -- Wendy's, Rheinmetall, Kioxia, IBM, TUI, DroneShield, QUALCOMM, Ölmarkt, Infineon, Alibaba, Take Two im Fokus
Top News
DroneShield-Aktie tiefrot: Warum der Kurs trotz Europa-Offensive unter Druck steht DroneShield-Aktie tiefrot: Warum der Kurs trotz Europa-Offensive unter Druck steht
KI-Euphorie kehrt zurück: DAX schließt klar im Plus - wieder näher an 25.000-Punkte-Marke KI-Euphorie kehrt zurück: DAX schließt klar im Plus - wieder näher an 25.000-Punkte-Marke
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & Musterdepots Tools & integriertes Trading Newsletter, Trading-Desk uvm.
Schon einen Account? Anmelden
Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Novavax Aktie

Kaufen
Verkaufen
Novavax Aktien-Sparplan
7,45 EUR -0,49 EUR -6,17 %
FSE
8,43 USD -0,47 USD -5,23 %
BTT
finanzen.net zero
Novavax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.1,30 Mrd. EUR

KGV2,64Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PKMZ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS6700024010

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolNVAX

Novavax Aktien News

DatumMeistgelesen
ZacksNovavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
PR NewswireNuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
PR NewswireNovavax to Participate in the Cantor Global Healthcare Conference
ZacksWhy Novavax (NVAX) is a Top Momentum Stock for the Long-Term
PR NewswireNovavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
ZacksNovavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
BenzingaNovavax Shares Are Trading Higher Thursday: What's Going On?
ZacksInvestors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
MotleyFoolNovavax (NVAX) Profit Jumps on Milestone
BenzingaNovavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
ZacksNovavax (NVAX) Q2 Earnings and Revenues Top Estimates
PR NewswireNovavax Reports Second Quarter 2025 Financial Results and Operational Highlights
BenzingaNovavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector
ZacksNovavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
PR NewswireNovavax to Report Second Quarter 2025 Financial Results on August 6, 2025
ZacksHere is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
ZacksNovavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
BenzingaNovavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates
PR NewswireNovavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study
ZacksNovavax (NVAX) Rises Higher Than Market: Key Facts
ZacksIs Trending Stock Novavax, Inc. (NVAX) a Buy Now?
ZacksNovavax (NVAX) Dips More Than Broader Market: What You Should Know
ZacksIs Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
ZacksNovavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
ZacksNovavax (NVAX) Ascends While Market Falls: Some Facts to Note
PR NewswireNovavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial
PR NewswireNovavax to Participate in Upcoming Investor Conferences
PR NewswireU.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
PR NewswireNovavax Reports First Quarter 2025 Financial Results and Operational Highlights
PR NewswireNovavax to Participate in BofA Securities 2025 Health Care Conference
PR NewswireNovavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan
PR NewswireNovavax to Report First Quarter 2025 Financial Results on May 8, 2025
PR NewswireNovavax Appoints Charles Newton to Board of Directors
PR NewswireSHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA
PR NewswireNovavax Announces Changes to Board of Directors
PR NewswireNovavax to Participate in Upcoming March Investor Conferences
PR NewswireNovavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
PR NewswireNovavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025
PR NewswireNovavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
PR NewswireNovavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza

Novavax News

Novavax News: auf dieser Seite finden Sie alle Novavax News und Nachrichten zur Novavax Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novavax News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novavax News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.